Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia

Behary, J., & Kumbhari, V. (2015). Advances in the Endoscopic Management of Obesity. Gastroenterology Research and Practice, 2015(), 451-459-164. https://doi.org/10.1155/2015/757821
Grave, R. D., Calugi, S., Centis, E., Ghoch, M. E., & Marchesini, G. (2011). Cognitive-Behavioral Strategies to Increase the Adherence to Exercise in the Management of Obesity. Journal of Obesity, 2011(), 267-277. https://doi.org/10.1155/2011/348293
Riera, J. B., Guri, A. J., & Hontecillas, R. (2011). Treatment of Obesity-Related Complications with Novel Classes of Naturally Occurring PPAR Agonists. Journal of Obesity, 2011(), 913-919. https://doi.org/10.1155/2011/897894
Lee, W. J., Chen, H. H., Wang, W., Wei, P. L., Lin, C. M., & Huang, M. T. (2003). Metabolic Syndrome in Obese Patients Referred for Weight Reduction Surgery in Taiwan. Journal of the Formosan Medical Association, 102(7), 459-464. https://doi.org/10.29828/JFMA.200307.0003
Glandt, M., & Raz, I. (2011). Present and Future: Pharmacologic Treatment of Obesity. Journal of Obesity, 2011(), 685-697. https://doi.org/10.1155/2011/636181